Regeneron Pharmaceuticals Inc (REGN) revenue is $14.34B
Regeneron Pharmaceuticals Inc (REGN) revenue is $14.34B as of 2025-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full REGN research page for quote, filings, and the rest of the model. This satellite exists so “Regeneron Pharmaceuticals Inc revenue” can rank with the actual number, then send you to /stock/regn.